Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
|
|
|
15.
|
Interleukin-2/interferon-alpha2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). [electronic resource] by
- Atzpodien, J
- Kirchner, H
- Rebmann, U
- Soder, M
- Gertenbach, U
- Siebels, M
- Roigas, J
- Raschke, R
- Salm, S
- Schwindl, B
- Müller, S C
- Hauser, S
- Leiber, C
- Huland, E
- Heinzer, H
- Siemer, S
- Metzner, B
- Heynemann, H
- Fornara, P
- Reitz, M
Producer: 20060915
In:
British journal of cancer vol. 95
Availability: No items available.
|